WebJul 20, 2024 · Rivus Pharmaceuticals General Information. Description. Developer of controlled metabolic accelerators created to improve cardio-metabolic health. The company's accelerators are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases, providing … WebRIVUS PHARMACEUTICALS INC. is a Virginia Foreign Corporation filed on March 15, 2024. The company's filing status is listed as Active and its File Number is F2118521. The Registered Agent on file for this company is Allen Cunningham and is located at 706b Forest St, Chrarlottesville, VA 22903-0000.
Rivus Pharmaceuticals Closes $132M Series B Financing
WebSep 22, 2024 · About Rivus Pharmaceuticals Rivus Pharmaceuticals, Inc., a leader in mitochondrial biology, is dedicated to improving cardio-metabolic health by advancing a new class of medicines, Controlled ... WebSep 22, 2024 · About Rivus Pharmaceuticals Rivus Pharmaceuticals, Inc., a leader in mitochondrial biology, is dedicated to improving cardio-metabolic health by advancing a … shreveport craigslist boats
Rivus Pharmaceuticals Launches with $35 Million Series A …
Web21 hours ago · As per DelveInsight's assessment, globally, about 75+ key pharma and biotech companies are working on 90+ pipeline drugs in the Heart Failure therapeutics landscape based on different Routes of ... WebFunding. Rivus Pharmaceuticals has raised a total of $167M in funding over 2 rounds. Their latest funding was raised on Sep 22, 2024 from a Series B round. Rivus Pharmaceuticals is funded by 6 investors. RxCapital and BB Biotech Ventures are the most recent investors. WebFor its lead program HU6, Rivus Pharmaceuticals has completed Phase 1 clinical studies and a Phase 2a metabolic study. Building on data from the metabolic study, Rivus … shreveport craigslist farm and garden